Maxigen Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	825.25	811.56	680.65	622.12	604.43	511.98
Revenue	825.25	811.56	680.65	622.12	604.43	511.98
Revenue Growth (YoY)	12.93%	19.23%	9.41%	2.93%	18.06%	11.86%
Cost of Revenue	252.21	247.84	197.33	198.02	230.44	250.95
Gross Profit	573.04	563.72	483.33	424.09	373.99	261.03
Selling, General & Admin	170.81	183.89	176.98	205.45	141.03	92.38
Research & Development	129.16	126.11	111.97	68.6	99.63	75.68
Operating Expenses	305.62	302.68	303.42	274.24	245.38	171.08
Operating Income	267.42	261.04	179.91	149.85	128.62	89.95
Interest Expense	-0.1	-0.04	-	-	-0.07	-0.2
Interest & Investment Income	35.97	35.28	27.43	25.02	3.18	0.48
Currency Exchange Gain (Loss)	3.83	3.83	17.14	4	31.69	-3.6
Other Non Operating Income (Expenses)	6.61	4.78	1.05	0.66	1.08	10.84
EBT Excluding Unusual Items	313.73	304.89	225.53	179.53	164.5	97.47
Gain (Loss) on Sale of Investments	-	-	0.02	-	-	-
Gain (Loss) on Sale of Assets	-	-	-0	13.62	1.03	-
Other Unusual Items	-	-	-	-	0.26	-
Pretax Income	313.73	304.89	225.55	193.14	165.78	97.47
Income Tax Expense	42.71	39.58	35.38	27.31	26.38	9.8
Net Income	271.02	265.31	190.17	165.83	139.4	87.67
Net Income to Common	271.02	265.31	190.17	165.83	139.4	87.67
Net Income Growth	29.77%	39.52%	14.68%	18.95%	59.01%	38.47%
Shares Outstanding (Basic)	90	90	89	89	89	84
Shares Outstanding (Diluted)	90	90	90	89	89	85
Shares Change (YoY)	-0.47%	0.77%	0.27%	0.07%	5.78%	4.81%
EPS (Basic)	3.02	2.96	2.13	1.86	1.57	1.04
EPS (Diluted)	3.02	2.94	2.12	1.85	1.56	1.04
EPS Growth	30.46%	38.68%	14.59%	18.59%	50.28%	31.75%
Free Cash Flow	210.84	208.36	266.45	148.76	254.05	103.34
Free Cash Flow Per Share	2.35	2.31	2.97	1.66	2.84	1.22
Dividend Per Share	-	-	0.830	1.000	0.476	-
Dividend Growth	-	-	-17.00%	110.00%	-	-
Gross Margin	69.44%	69.46%	71.01%	68.17%	61.88%	50.98%
Operating Margin	32.41%	32.16%	26.43%	24.09%	21.28%	17.57%
Profit Margin	32.84%	32.69%	27.94%	26.66%	23.06%	17.12%
Free Cash Flow Margin	25.55%	25.67%	39.15%	23.91%	42.03%	20.18%
EBITDA	301.78	293.07	206.75	177.09	156.71	119.73
EBITDA Margin	36.57%	36.11%	30.38%	28.47%	25.93%	23.39%
D&A For EBITDA	34.36	32.03	26.85	27.24	28.09	29.79
EBIT	267.42	261.04	179.91	149.85	128.62	89.95
EBIT Margin	32.41%	32.16%	26.43%	24.09%	21.28%	17.57%
Effective Tax Rate	13.61%	12.98%	15.69%	14.14%	15.91%	10.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.